Fluorescent dye mapping during stomach cancer surgery
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial studies whether a fluorescent dye (a “tracer”) can help surgeons find the right area during laparoscopic distal (lower-part) stomach removal for early stomach cancer. It may improve how completely the cancer is removed while keeping surgery minimally invasive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 75 years old
- Your stomach cancer is confirmed by biopsy as adenocarcinoma
- The cancer is early (T1) with no distant spread, and it’s in the lower third of the stomach
- You have no spread to far-away organs, and no tumor is invading nearby major organs
- You’re well enough for surgery (ECOG 0–1 and ASA I–III)
- You can be scheduled for laparoscopic distal gastrectomy and agree in writing to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special dye called indocyanine green can help surgeons find sentinel lymph nodes during surgery for esophageal cancer. It may help doctors know which lymph nodes to remove for better staging.
This trial tests if a special dye (ICG) and a near-infrared camera can help surgeons see and protect a nerve that controls your voice box during minimally invasive esophagus cancer surgery. The goal is to reduce voice changes after surgery.
This trial tests a special dye called indocyanine green to help surgeons see blood flow during surgery to remove part of the colon. If you have colorectal disease and need surgery, this could help make your operation safer.
This trial tests a new technique that uses a special dye to highlight the first lymph nodes where stomach cancer might spread, allowing surgeons to remove only the necessary nodes during surgery. The goal is to reduce side effects while still effectively treating the cancer.
This Phase 2 study tests whether using a special light-activated dye (indocyanine green) during laparoscopic stomach surgery can improve surgical outcomes for people with remnant (leftover) stomach cancer that has not spread to distant organs. It may help surgeons better find lymph nodes while operating.
This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.